Table 3.
Clinical features | N | % of cases |
---|---|---|
Agitation/anxiety | 24 | 59 |
Tachycardia (≥ 100/min) | 22 | 54 |
Hypertension (systolic blood pressure ≥ 140 mmHg) | 15 | 37 |
Mydriasis | 10 | 24 |
Reduced level of consciousness (RLS > 2) | 7 | 17 |
Miosis | 6 | 15 |
Hallucinations | 5 | 12 |
Rhabdomyolysis (CK > 25 μkat/L [∼ 1500 U/L] or myoglobin > 3000 μg/L) | 4 | 10 |
Diaphoresis | 4 | 10 |
Delirium | 3 | 7 |
Seizures | 3 | 7 |
Hypokalemia (≤ 3.3 mmol/L or mEq/L) | 3 | 7 |
Clinical significant hyperthermia (> 39.0 °C [102.2 °F]) | 2 | 5 |
RLS reaction level scale [22], CK creatine kinase